Global Cord Blood (NYSE:CO) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report published on Monday. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Price Performance

Shares of NYSE:CO opened at $1.25 on Monday. The company has a market capitalization of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16. The firm’s 50 day simple moving average is $1.57 and its 200 day simple moving average is $1.38. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.